CJ
IDXX icon

Caitlin John’s Idexx Laboratories IDXX Stock Holding History

Caitlin John’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.81K Hold
5
– – ﹤0.01% 678
2025
Q4 		$3.38K Hold
5
– – ﹤0.01% 675
2025
Q3 		$3.19K Buy
+5
New +$3.04K ﹤0.01% 640
2025
Q1 		– Sell
-25
Closed -$10.3K – 425
2024
Q4 		$10.3K Hold
25
– – 0.01% 477
2024
Q3 		$10.7K Hold
25
– – 0.01% 480
2024
Q2 		$12.2K Hold
25
– – 0.01% 431
2024
Q1 		$13.5K Hold
25
– – 0.01% 411
2023
Q4 		$13.9K Buy
+25
New +$11.7K 0.01% 386

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Caitlin John's IDXX Position: Q1 2026 in Review

Caitlin John held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 5 shares worth $2.81K. The position accounts for ﹤0.01% of the portfolio, ranked #678.

Caitlin John first reported a position in IDXX in Q4 2023 and has held it in 8 quarters since. The position peaked at $13.9K in Q4 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Caitlin John held 5 shares of Idexx Laboratories worth $2.81K as of Q1 2026.
  • Caitlin John left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up ﹤0.01% of Caitlin John's portfolio in Q1 2026, its #678 holding.
  • Caitlin John first reported a position in Idexx Laboratories in Q4 2023 and has held it in 8 quarters since.
  • Caitlin John's Idexx Laboratories position peaked at $13.9K in Q4 2023.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.